Market Research Reports By Publisher

Datamonitor

Previous 1 2 3 4 5 6 7 8 9 10 Next

Daiichi Sankyo Co., Ltd: PharmaVitae Profile
Published by Datamonitor in June 2010
IntroductionThis analysis examines the historical and forecast performance for Daiichi Sankyo in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f...(more)

Astellas Pharma Inc.: PharmaVitae Profile
Published by Datamonitor in June 2010
IntroductionThis analysis examines the historical and forecast performance for Astellas in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecas...(more)

Eisai Co. Ltd: PharmaVitae Profile
Published by Datamonitor in June 2010
IntroductionThis analysis examines the historical and forecast performance for Eisai in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales ...(more)

Takeda Pharmaceutical Co. Ltd: PharmaVitae Profile
Published by Datamonitor in June 2010
IntroductionThis analysis examines the historical and forecast performance for Takeda in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales...(more)

Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile
Published by Datamonitor in June 2010
IntroductionThis analysis examines the historical and forecast performance for Mitsubishi Tanabe in the Rx drug sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecast...(more)

Forecast Insight: HIV – Increasing dominance of fixed dose combinations raises bar for single agents
Published by Datamonitor in June 2010
IntroductionIn 2009, HIV antiretroviral sales across the seven major markets totalled $11.8 billion, growing at a CAGR of 10.8% between 2005 and 2009. While new cross-class fixed dose combinations will ensure market growth until 2015, Datamonitor expects major patent ex...(more)

Novartis AG: PharmaVitae Profile
Published by Datamonitor in June 2010
IntroductionThis analysis examines the historical and forecast performance for Novartis in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forec...(more)

GlaxoSmithKline plc: PharmaVitae Profile
Published by Datamonitor in June 2010
IntroductionThis analysis examines the historical and forecast performance for GSK in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fo...(more)

UK Pharmaceutical Market Overview - Pricing and reimbursement challenges dampen future growth
Published by Datamonitor in June 2010
IntroductionThe UK prescription pharmaceutical market was valued at $28.4 billion in 2009. Key growth drivers include growing use of chronic high-value innovative treatments driven by a rising elderly population, high public healthcare expenditure as proportion of total...(more)

Stakeholder Opinions: Hemophilia - The harsh reality of commercialising a great research opportunity?
Published by Datamonitor in June 2010
Globally, the osteoporosis market displayed a 3.5% compound annual growth rate (CAGR) between 2005–09, reaching $9.4 billion in 2009. However, the launch of generic alendronate in the majority of markets resulted in a temporary decline in sales during 2009. The market w...(more)

Previous 1 2 3 4 5 6 7 8 9 10 Next

Home | About | Market Research by Sector |
Pharmaceutical Research Firms | Pharmaceutical Suppliers Directory | faq | Privacy | Terms
Site Contents